FarmaForce Limited announced unaudited consolidated earnings results for the half year ended December 31, 2016. For the half year period, the company's revenue was AUD 1,612,898 compared with AUD 1,362,134 a year ago. Offsetting this revenue increase was an increase in labor costs as a result of timing of the inception of new contracts against an earlier commencement of its larger sales teams. Loss before income tax was AUD 1,534,968 compared with AUD 1,483,298 a year ago. Loss for the period was AUD 1,534,968 or 0.01 cents per basic and diluted share compared with AUD 1,483,298 or 0.07 cents per basic and diluted share a year ago. Net cash used by operating activities was AUD 1,061,760 compared with AUD 1,725,105 a year ago. Purchase of property, plant and equipment was AUD 17,763 compared with AUD 111,841 a year ago. Loss from ordinary activities after tax attributable to members was AUD 1,535,000 compared with AUD 1,483,000 a year ago.